Healthcare >> CEO Interviews >> November 17, 2008
JOHN C. SCHAFER, President and Chief Executive Officer of DiagnoCure Inc., has
accumulated over 30 years' experience in the field of diagnostics, along with an
excellent track record in management and growth of high technology diagnostics
companies. He holds a BA in Biology and Chemistry from Carthage College and has
advanced coursework in medical technology from St. Luke's School of Medicine,
healthcare administration from Central Michigan University, and finance from
Boston University. Before joining DiagnoCure, Mr. Schafer led a Montreal-based
biosensor company with target applications in biodefense, medical diagnostics
and immunodiagnostics. Prior to that, as President and CEO of Boston Medical
Technologies, he led the introduction of an important new diagnostic instrument
for physicians treating patients with diabetic autonomic neuropathy. During his
14 years at Baxter International, Mr. Schafer held key sales, marketing and
operational positions prior to being named President and General Manager of
several Baxter diagnostic divisions. Mr. Schafer spent three years as a Vice
President of Business Development in the Life Science division of $6 billion
consulting firm CAP-Gemini. He is the past Director of numerous life sciences
companies and has received numerous awards as a leading biotech
entrepreneur. Mr. Schafer has been President and CEO of DiagnoCure since August
23, 2006. Profile
Mr. Schafer: DiagnoCure is a rather unique life sciences company because we do
two things that could put us into
